Discussion
An experimental device designed to continuously measure cortisol and help diagnose and manage cortisol-related disorders, including Cushing’s disease, received breakthrough device designation from the U.S. Food and Drug Administration (FDA). The designation is intended for medical devices that may provide more effective diagnosis or treatment for life-threatening or irreversibly…